Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082209 | SCV000114158 | benign | not specified | 2012-11-28 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224586 | SCV000280945 | likely benign | not provided | 2015-08-19 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000082209 | SCV000518680 | benign | not specified | 2016-04-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000224586 | SCV000840745 | benign | not provided | 2018-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082029 | SCV001012410 | benign | ALG9 congenital disorder of glycosylation | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490723 | SCV002799487 | likely benign | ALG9 congenital disorder of glycosylation; Gillessen-Kaesbach-Nishimura syndrome | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224586 | SCV005212183 | likely benign | not provided | criteria provided, single submitter | not provided |